Status:
COMPLETED
V260 Registration Study (V260-013)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rotavirus
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
Immunogenicity and Safety of V260 in Healthy Infants in Korea
Eligibility Criteria
Inclusion
- At first study vaccination, age 6 weeks through exactly 12 weeks
Exclusion
- History of congenital abdominal disorders, intussusception, or abdominal surgery
- History of known prior rotavirus disease
- Ongoing chronic diarrhea or failure to thrive
- Clinical evidence of active gastrointestinal illness
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00166517
Start Date
August 1 2005
End Date
July 1 2006
Last Update
April 1 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.